Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2020

Dec 23, 2020

31802_dirs_2020-12-23_29c0cea6-04e3-4dd6-9cda-d5120245f325.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2020-12-21

Reporting Person: CARREL MICHAEL H (Director, President, CEO, & Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-21 Common Stock M 24751 $21.04 Acquired 529255 Direct
2020-12-21 Common Stock S 24751 $55.00 Disposed 504504 Direct
2020-12-22 Common Stock M 25000 $21.04 Acquired 529594 Direct
2020-12-22 Common Stock S 25000 $56.00 Disposed 504504 Direct
2020-12-22 Common Stock M 25000 $21.04 Acquired 529504 Direct
2020-12-22 Common Stock S 25000 $57.00 Disposed 504504 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-21 Stock Option (Right to Buy) $21.04 M 24751 Disposed 2024-01-24 Common Stock (24751) Direct
2020-12-22 Stock Option (Right to Buy) $21.04 M 25000 Disposed 2024-01-24 Common Stock (25000) Direct
2020-12-22 Stock Option (Right to Buy) $21.04 M 25000 Disposed 2024-01-24 Common Stock (25000) Direct

Footnotes

F1: These shares were exercised pursuant to a 10b5-1 trading plan.

F2: These shares were sold pursuant to a 10b5-1 trading plan.

F3: These options were granted on January 24, 2014. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.

F4: Options to purchase shares in 25,000 increments were granted on January 24, 2014 and vest at each Option Trigger Event. "Option Trigger Event" shall mean the volume adjusted weighted average closing price of common stock of the Company as reported by NASDAQ (or any other exchange on which the common stock of the Company is listed) for 30 consecutive days equals or exceeds each of $10.00 per share, $12.50 per share, $15.00 per share, $17.50 per share, $20.00 per share, $25.00 per share, $30.00 per share, $35.00 per share and $40.00 per share.